PharmaCyte Biotech, Inc.
PMCB
$1.19
$0.043.48%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.60% | -36.14% | -34.96% | -18.02% | -16.64% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -57.95% | 105.33% | -7.54% | -12.76% | -7.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -20.48% | -35.11% | -34.82% | -17.99% | -16.60% |
|
|
|||||
| Total Current Assets | -20.48% | -35.11% | -34.82% | -17.99% | -16.60% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | -56.35% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -9.17% | 10.69% | -15.98% | 67.34% | 61,324.68% |
| Total Assets | -20.45% | -21.51% | 17.18% | -16.05% | -9.53% |
|
|
|||||
| Total Accounts Payable | 39.10% | -37.08% | 42.27% | -19.58% | 283.68% |
| Total Accrued Expenses | 0.31% | 3.38% | -6.95% | -5.06% | -23.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -40.33% | 1,245.47% | -53.24% | 72.53% |
| Total Other Current Liabilities | -- | -40.33% | 1,245.47% | -53.24% | 72.53% |
| Total Current Liabilities | -74.99% | -36.09% | 370.62% | -29.42% | 30.89% |
|
|
|||||
| Total Current Liabilities | -74.99% | -36.09% | 370.62% | -29.42% | 30.89% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -65.30% | -29.02% | -25.35% | -13.12% | -4.15% |
| Total Liabilities | -69.28% | -32.10% | 17.84% | -15.26% | -0.67% |
|
|
|||||
| Common Stock & APIC | 0.04% | -0.75% | -1.41% | -2.05% | -2.26% |
| Retained Earnings | -3.25% | -1.59% | 20.26% | 1.15% | -0.53% |
| Treasury Stock & Other | -0.52% | -3.31% | -1.78% | -2.90% | -1.00% |
| Total Common Equity | -7.37% | -8.92% | 72.56% | -11.88% | -14.67% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | 10.29% | 50.22% |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -55.06% | -32.26% | -17.74% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -69.87% | -22.39% | -8.10% |
|
|
|||||
| Total Common Equity | -7.37% | -8.92% | 72.56% | -11.88% | -14.67% |
| Total Preferred Equity | -- | -- | -69.87% | -22.39% | -8.10% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.37% | -18.08% | 16.97% | -16.31% | -12.02% |
|
|
|||||